Clinical Application/Social Implementation

1. Endoscopy Diagnosis Support AI System (Colorectal lesion detection) [Japan, Pharmaceutical Affairs Approval: Controlled Medical Device (Class II)]
   Product name: WISE VISION (NEC) Nov. 2020
2. Endoscopy Diagnosis Support AI System (Colorectal lesion detection) [Europe, CE Mark acquisition]
   Product name: WISE VISION ( NEC) Dec. 2020
3. Endoscopy diagnosis support AI system (Barrett's esophagus tumor detection) [Europe, CE Mark acquisition]
   Product name: WISE VISION (NEC) May 2021
4. AI development support platform [Market launch]
   Product name: SYNAPSE Creative Space ( (FUJIFILM) April 2022
5. AI technology to precisely extract suspected glioma areas from MRI images [Japan, Certification under the Pharmaceutical Affairs Law]
   Product name: SYNAPSE Creative Space (FUJIFILM) February 2024
6. AI system to support fetal cardiac ultrasound diagnosis [Japan, Pharmaceutical Affairs Approval: Controlled Medical Devices (Class II)]
   Product name: HOPE LifeMark Fetal Echocardiography Screening Support System (FUJITSU) July, 2024
7. Endoscopic diagnosis support AI system (Differential diagnosis of colon) [Japan, Pharmaceutical Affairs Approval: highly controlled medical devices (Class III)]
   Product name WISE VISION Endoscope Image Analysis AI A1000 (NEC) Approval: Mar 2025

Joint project with local government (demonstration experiment)

Community Healthcare Project to Make Shimizu Ward a City with Less Stroke by Early Detection of Atrial Fibrillation Using AI and Remote Technology (abbreviated name SPAFS): Joint project with Shimizu Ward, Shizuoka City, Tokyo Medical and Dental

University, Fukuda Denshi and others → Analysis had been completed as of end of January 2023 Of the 336 participants (350 total participants), 9 (approximately 2.7%) were found to have atrial fibrillation.